CORCEPT THERAPEUTICS INC (CORT)
US2183521028 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 111.80M | 66.30M | 77.60M | 76.20M | 31.30M | |||
| Marketable Securities | 243.40M | 365.30M | 145.90M | 364.50M | 244.70M | |||
| Receivables | 34.60M | 31.10M | 27.60M | 26.20M | 19.90M | |||
| Inventories | 7.50M | 6.10M | 5.00M | 4.90M | 5.40M | |||
| Other Current Assets | 34.20M | 30.40M | 10.30M | 6.70M | 6.00M | |||
| Total Current Assets | 431.50M | 499.30M | 266.50M | 478.50M | 307.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 500.00K | 1.80M | 1.50M | 4.20M | 4.50M | |||
| Investments And Advances | 59.60M | 4.90M | 112.30M | 36.20M | 39.40M | |||
| Other Non-Current Assets | 102.40M | 77.50M | 43.50M | 52.90M | 61.10M | |||
| Total Non-Current Assets | 162.50M | 84.10M | 157.30M | 93.20M | 104.90M | |||
| TOTAL ASSETS | 594.00M | 583.40M | 423.80M | 571.70M | 412.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 75.10M | 60.40M | 40.10M | 36.90M | 30.80M | |||
| Accounts Payable | 16.70M | 12.00M | 6.90M | 10.60M | 7.50M | |||
| Other Current Liabilities | 30.00M | 100.00K | 500.00K | N/A | 500.00K | |||
| Total Current Liabilities | 121.90M | 72.50M | 47.50M | 47.50M | 38.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 10.50M | 9.10M | 400.00K | 900.00K | 2.30M | |||
| Total Non-Current Liabilities | 10.40M | 9.10M | 500.00K | 900.00K | 2.30M | |||
| TOTAL LIABILITIES | 132.30M | 81.60M | 48.00M | 48.40M | 41.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 371.20M | 296.40M | 195.00M | 82.50M | -23.60M | |||
| Additional Paid In Capital | 722.40M | 662.30M | 591.30M | 516.10M | 457.10M | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -631.80M | -456.10M | -410.40M | -75.80M | -62.70M | |||
| Other Shareholders' Equity | -200.00K | -900.00K | -200.00K | 400.00K | 300.00K | |||
| Shares Outstanding | 103.00M | 131.00M | 105.90M | 116.70M | 114.50M | |||
| Tangible Book Value per Share | 4.48 | 3.83 | 3.55 | 4.48 | 3.24 | |||
| Total Shareholders' Equity | 461.70M | 501.80M | 375.80M | 523.30M | 371.20M | |||
| TOTAL LIABILITIES AND EQUITY | 594.00M | 583.40M | 423.80M | 571.70M | 412.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.54 | 6.89 | 5.61 | 10.07 | 7.92 | |||
| Return On Assets (ROA) | 15.39% | 17.38% | 26.55% | 18.54% | 22.85% | |||
| Return On Equity (ROE) | 19.80% | 20.21% | 29.94% | 20.26% | 25.38% | |||
| Return On Invested Capital (ROIC) | 18.44% | 19.53% | 29.32% | 21.68% | 26.48% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 74.45% | 125.85% | 72.22% | 136.08% | 101.45% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 74.45% | 125.85% | 72.22% | 136.08% | 101.45% | |||
All data in USD